NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/18/2026
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Holders
Representatives
David H. Siegel Norris McLaughlin, P.A.
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, mental disorders and gastroenterological diseases; pharmaceutical preparations for the prevention of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, mental disorders and gastroenterological diseases; pharmaceutical preparations for the treatment of pre-diabetic conditions, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, non-alcoholic steatohepatitis, depression, motivational disorders, depressive moods and malabsorption disorders; pharmaceutical preparations for the prevention of pre-diabetic conditions, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, non-alcoholic steatohepatitis, depression, motivational disorders, depressive moods and malabsorption disorders; pharmaceutical preparations for improving mood and mental and physical wellbeing; food supplements and dietary preparations adapted for medical purposes for the treatment of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, psychic disorders and gastroenterological diseases; food supplements and dietary preparations adapted for medical purposes for the prevention of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, psychic disorders and gastroenterological diseases; food supplements and dietetic preparations adapted for medical purposes for the treatment of pre-diabetic states, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, depression, motivational disorders, depressed mood and malabsorption disorders; food supplements and dietetic preparations adapted for medical purposes for the prevention of pre-diabetic states, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, depression, motivational disorders, depressed mood and malabsorption disorders; food supplements and dietetic preparations adapted for medical purposes for improving mood and mental and physical well-being all of the foregoing excluding any goods that consist of, contain or are derived from cannabis, marijuana or hemp
Class 42
Pharmaceutical research and development services; biochemical research and development services; medical research and development services; all of the foregoing excluding services in relation to any goods that consist of, contain or are derived from cannabis, marijuana or hemp
History of USPTO decisions and trademark events.
32 publications found
NEW REPRESENTATIVE AT IB RECEIVED
06/18/2026
FINAL DECISION TRANSACTION PROCESSED BY IB
05/28/2026
FINAL DISPOSITION NOTICE SENT TO IB
05/12/2026
FINAL DISPOSITION PROCESSED
05/12/2026
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/04/2026
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2025
REGISTERED-PRINCIPAL REGISTER
11/04/2025
CHANGE OF OWNER RECEIVED FROM IB
10/02/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/16/2025
PUBLISHED FOR OPPOSITION
09/16/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
08/13/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
08/12/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2025
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/27/2025
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/10/2025
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/10/2025
REFUSAL PROCESSED BY IB
04/19/2025
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/28/2025
REFUSAL PROCESSED BY MPU
03/28/2025
ATTORNEY REVIEW COMPLETED
09/09/2024
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
09/09/2024
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/17/2024
NON-FINAL ACTION WRITTEN
06/16/2024
ASSIGNED TO EXAMINER
06/15/2024
LIMITATION FROM THE IB EXAMINED AND ENTERED
06/10/2024
LIMITATION OF GOODS RECEIVED FROM IB
05/26/2024
LIMITATION OF GOODS RECEIVED FROM IB
04/28/2024
APPLICATION FILING RECEIPT MAILED
01/20/2024
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/16/2024
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/11/2024
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.